Memorial Sloan Kettering Cancer Center Onco-Nephrology Symposium 2024
65 $
Format : 34 videos + 27 pdfs
File size: 8.17 GB
Date & Location: Friday, September 13, 2024, 8:00 AM – Saturday, September 14, 2024, 2:20 PM, Zuckerman Research Center, 417 East 68th Street, New York, NY
Specialties – Bioethics, Cardiology, Critical Care, Endocrinology, Diabetes and Metabolism, General and Family Practice, Genitourinary Oncology, Hematology, Hospitalist, Internal Medicine, Medical Oncology, Molecular Pathology, Myeloma, Nephrology, Nurse Practitioner, Nursing, Oncology and Hematology, Pathology, Physician Assistant, Surgical Pathology, Urology
Overview
The 2024 Onco-Nephrology Symposium welcomes all members of the healthcare team who manage patients with both cancer and kidney disease. This year’s program embraces the multidisciplinary nature of onco-nephrology and features experts in plasma cell disorders such as multiple myeloma, amyloidosis, monoclonal gammopathies as well as renowned speakers on CAR T cell, other biologic therapies, thrombotic microangiopathy, and cardio-renal syndromes. The goal of this forum is to allow academicians, clinicians, and clinical experts to have personal exchanges and robust discussions in order to enhance the clinical experiences and outcomes of patients.
The target audience for this program includes physicians, advanced practice providers, nurses, medical students, and other healthcare professionals interested in the care of cancer patients with kidney disease. This symposium offers attendees the option to participate either in person at Memorial Sloan Kettering’s Zuckerman Research Center (417 East 68th Street, New York City) or virtually via Zoom.
Objectives
At the conclusion of this symposium, attendees will be able to:
- Outline a comprehensive assessment and treatment of thrombotic microangiopathy
- Strategize a treatment plan for the patient with MGRS as part of a multidisciplinary team
- Effectively utilize novel diagnostic techniques to diagnose monoclonal disorders
- Recognize renal and non-renal toxicities of modern cancer therapy
- Formulate an treatment plan for kidney transplant patients who receive CAR T cell therapy
- Assimilate genetic testing data in the evaluation of thrombotic microangiopathy
- Review assessment and management of glomerular disorders in cancer patients
- Apprehend modern therapeutic approaches to small renal masses and cancers of the kidney
+ Topics:
Abstracts.pdf
An Update on Radiation Nephropathy – From EBRT to Therapeutic Isotopes.mp4
An Update on Radiation Nephropathy – From EBRT to Therapeutic Isotopes.pdf
Beyond the Kidneys Q&A and Panel Discussion.mp4
CAR T Alphabet Soup.mp4
CAR T Alphabet Soup.pdf
CAR T Cell Therapy Q&A and Panel Discussion I.mp4
CAR T Cell Therapy Q&A and Panel Discussion II.mp4
CAR T Therapy in Patients with MM and ESRD.mp4
CAR T Therapy in Patients with MM and ESRD.pdf
CARs and Solid Organ Transplant.mp4
CARs and Solid Organ Transplant.pdf
Case Discussions.mp4
Complement Studies and Interpreting Genetic Testing & Role of Eculizumab and Other Therapies in Non-TA-TMA.mp4
Complement Studies and Interpreting Genetic Testing & Role of Eculizumab and Other Therapies in Non-TA-TMA.pdf
Diagnosis, Management, and Prognosis of Cardiac Amyloidosis.mp4
Diagnosis, Management, and Prognosis of Cardiac Amyloidosis.pdf
Endocrine Toxicities From ICPI.mp4
Endocrine Toxicities From ICPI.pdf
Glomerular and Tubular Matters Q&A and Panel Discussion.mp4
Glomerular Diseases in Chronic GVHD.mp4
Glomerular Diseases in Chronic GVHD.pdf
How I Assess Treatment Response in Plasma Cell Disorders.mp4
How I Assess Treatment Response in Plasma Cell Disorders.pdf
How I Treat AL Amyloidosis with Kidney Involvement.mp4
How I Treat AL Amyloidosis with Kidney Involvement.pdf
How I Treat Monoclonal Gammopathy of Renal Significance (MGRS).mp4
How I Treat Monoclonal Gammopathy of Renal Significance (MGRS).pdf
How I Treat Multiple Myeloma.mp4
How I Treat Multiple Myeloma.pdf
How I Use Serum Free Light Chains in Clinical Practice.mp4
How I Use Serum Free Light Chains in Clinical Practice.pdf
Let’s Go to the Data- Eculizumab, Narsoplimab in TA-TMA.mp4
Let’s Go to the Data- Eculizumab, Narsoplimab in TA-TMA.pdf
Management of BK Nephropathy Post-SCT.mp4
Management of BK Nephropathy Post-SCT.pdf
Mass Spectrometry Made Simple.mp4
Mass Spectrometry Made Simple.pdf
Modern Approach to the Diagnosis and Treatment of Renal Cancer.mp4
Modern Approach to the Diagnosis and Treatment of Renal Cancer.pdf
Modern Approach to the Diagnosis and Treatment of Small Renal Masses.mp4
Modern Approach to the Diagnosis and Treatment of Small Renal Masses.pdf
Modern Approach to the Diagnosis and Treatment of Testicular Cancer.mp4
Modern Approach to the Diagnosis and Treatment of Testicular Cancer.pdf
Monoclonal Proteins Getting to the Heart of the Matter Q&A and Panel Discussion.mp4
Newer Methodologies to Detect Monoclonal Proteins in the Blood and Urine in Monoclonal Gammopathy of Renal Significance (MGRS).mp4
Newer Methodologies to Detect Monoclonal Proteins in the Blood and Urine in Monoclonal Gammopathy of Renal Significance (MGRS).pdf
Newer Methodologies to Detect Monoclonal Proteins on the Kidney Biopsy.mp4
Newer Methodologies to Detect Monoclonal Proteins on the Kidney Biopsy.pdf
Next Generation Therapy- CARTs and Beyond.mp4
Next Generation Therapy- CARTs and Beyond.pdf
OncoNeph2024_Brochure.pdf
Renal and Testicular Cancer Q&A and Panel Discussion.mp4
This is How We Do It Q&A and Panel Discussion.mp4
Thrombotic Microangiopathy Q&A and Panel Discussion.mp4
TMA- Demystifying the Complement Pathway.mp4
TMA- Demystifying the Complement Pathway.pdf
Updates in the Management of Cancer Treatment-Related Cardiac Toxicities.mp4
Updates in the Management of Cancer Treatment-Related Cardiac Toxicities.pdf
VEGF Inhibitors and TKIs- Stopping and Restarting After Kidney Injury.mp4
VEGF Inhibitors and TKIs- Stopping and Restarting After Kidney Injury.pdf
Related Products
